Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJAMA Oncol 2023 Aug 10;[EPub Ahead of Print], J Huober, P Weder, K Ribi, B Thürlimann, JC Thery, Q Li, L Vanlemmens, S Guiu, E Brain, J Grenier, F Dalenc, C Levy, AM Savoye, A Müller, V Membrez-Antonioli, MA Gérard, J Lemonnier, H Hawle, D Dietrich, E Boven, H Bonnefoi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.